Accelerating an Orphan Therapy to Market
April 8, 2021 - Cytiva Click here to learn more >> This case study shares the work of Cytiva’s Fast Trak Services team to help accelerate development of a process for cGMP productio…

Meeting the Process Development Challenges of a Diverse Biologic …
April 8, 2021 - Cytiva Click here to learn more >> In the current biopharmaceutical landscape, developers are constantly encountering new and diverse biological molecules with complex s…

Diamyd Medical Selects Cytiva’s FlexFactory Platform to Make Pr…
April 8, 2021 - Cytiva Click here to learn more >> Diamyd Medical will install a new Cytiva FlexFactory platform in Umeå, Sweden. Once up and running, the clinical-stage biopharmac…

A Small-Scale Model to Increase Yield in Cell Culture Perfusion o…
April 8, 2021 - Cytiva Click here to learn more >> We have developed a reliable small-scale model for a monoclonal antibody (mAb) perfusion process using TPP® TubeSpin® Bioreactor t…

Perfusion N-1 – A Way to Improve the Fed-Batch Production Proce…
April 8, 2021 - Cytiva Click here to read more >> In this article, we show how the conventional N-1 seed train step was replaced by a high-density perfusion and how the production b…

Sanitization Opportunities for Protein A Resins
April 8, 2021 - Cytiva Click here to read more >> Bacterial endospores present a challenge in bioproduction due to their resistance to common sanitization procedures using high concen…

Genetic Vaccine Platforms Demonstrate Their Potential
March 26, 2021 - BioPharm International In a pandemic, genetic vaccines offer several advantages over traditional approaches. By Cynthia A. Challener For a vaccine to be effecti…

Cytiva Advances Fiber Chromatography Technology with New Launch
March 26, 2021 - BioPharm International Editors The launch of HiScreen Fibro PrismA, the company’s newest product for early mAb purification process development strengthens Cytiva’s new fiber-based Protein A…

mRNA Therapeutics and Vaccines – Key Process Considerations
March 25, 2021 - Cytiva Click here >> Learn more on key considerations and strategies for process development and scaling up in our new web hub for mRNA therapeutics and vaccines.

Visualize your ÄKTA Pilot 600S in 3D
March 25, 2021 - Cytiva Click here to learn more >> Learning about relevant chromatography systems is crucial for a good fit with your applications and workflows. When when thi…

Next Page